Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Revenue, net $ 24,079 $ 21,896
Cost of revenue (excluding amortization of $3,652 and $3,252, respectively) 15,888 10,197
Gross profit 8,191 11,699
Operating expenses:    
Sales and marketing 11,116 8,421
Research and development 2,810 2,124
General and administrative 14,546 8,499
Acquisition related expense 2,534
Acquisition related amortization expense 3,652 3,252
Change in fair value of contingent consideration (44) 1,522
Total operating expenses 34,614 23,818
Operating loss (26,423) (12,119)
Accretion expense (440) (331)
Other income (expense), net 196 263
Loss from continuing operations before tax (26,667) (12,187)
(Benefit) provision for income taxes (28) 18
Loss from continuing operations, net of tax (26,639) (12,205)
Less Preferred stock dividends (429)
Loss from continuing operations attributable to common stockholders (27,068) (12,205)
(Loss) income from discontinued operations, net of tax (88) 16
Net loss attributable to common stockholders $ (27,156) $ (12,189)
Basic and diluted (loss) income per share of common stock:    
From continuing operations $ (7.23) $ (4.33)
From discontinued operations (0.02)
Net loss per basic and diluted share of common stock $ (7.25) $ (4.33)
Weighted average number of common shares and common share equivalents outstanding:    
Basic 3,746,000 2,816,000
Diluted 3,746,000 2,816,000